SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exelixis, Inc. – ‘10-Q’ for 9/30/22

On:  Tuesday, 11/1/22, at 4:16pm ET   ·   For:  9/30/22   ·   Accession #:  939767-22-110   ·   File #:  0-30235

Previous ‘10-Q’:  ‘10-Q’ on 8/9/22 for 7/1/22   ·   Next:  ‘10-Q’ on 5/9/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 4/30/24 for 3/29/24   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/01/22  Exelixis, Inc.                    10-Q        9/30/22   73:7.5M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.76M 
 2: EX-10.1     Material Contract                                   HTML     26K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
11: R1          Cover Page                                          HTML     74K 
12: R2          Condensed Consolidated Balance Sheets               HTML    130K 
13: R3          Condensed Consolidated Balance Sheets               HTML     39K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Income         HTML     93K 
15: R5          Condensed Consolidated Statements of Comprehensive  HTML     42K 
                Income                                                           
16: R6          Condensed Consolidated Statements of Comprehensive  HTML     25K 
                Income (Parenthetical)                                           
17: R7          Condensed Consolidated Statements of Stockholders'  HTML     73K 
                Equity                                                           
18: R8          Condensed Consolidated Statements of Cash Flows     HTML     99K 
19: R9          Organization and Summary of Significant Accounting  HTML     36K 
                Policies                                                         
20: R10         Revenues                                            HTML    121K 
21: R11         Collaboration Agreements And Business Development   HTML     65K 
                Activities                                                       
22: R12         Cash and Investments                                HTML    101K 
23: R13         Fair Value Measurements                             HTML     59K 
24: R14         Inventory                                           HTML     34K 
25: R15         Stock-Based Compensation                            HTML     59K 
26: R16         Provision For Income Taxes                          HTML     27K 
27: R17         Net Income Per Share                                HTML     49K 
28: R18         Commitments and Contingencies                       HTML     43K 
29: R19         Subsequent Events                                   HTML     27K 
30: R20         Organization and Summary of Significant Accounting  HTML     54K 
                Policies (Policies)                                              
31: R21         Revenues (Tables)                                   HTML    122K 
32: R22         Collaboration Agreements And Business Development   HTML     54K 
                Activities (Tables)                                              
33: R23         Cash and Investments (Tables)                       HTML    111K 
34: R24         Fair Value Measurements (Tables)                    HTML     53K 
35: R25         Inventory (Tables)                                  HTML     35K 
36: R26         Stock-Based Compensation (Tables)                   HTML     54K 
37: R27         Net Income Per Share (Tables)                       HTML     50K 
38: R28         Organization and Summary of Significant Accounting  HTML     32K 
                Policies (Details)                                               
39: R29         Revenues - Revenues by Disaggregated Category       HTML     41K 
                (Details)                                                        
40: R30         Revenues - Revenues Disaggregated by Concentration  HTML     45K 
                Risks (Details)                                                  
41: R31         Revenues - Revenues Disaggregated by Geographic     HTML     34K 
                Region (Details)                                                 
42: R32         Revenues - Net Product Revenues Disaggregated by    HTML     34K 
                Product (Details)                                                
43: R33         Revenues - Activities and Ending Reserve Balances   HTML     43K 
                for Significant Categories of Discounts and                      
                Allowances (Details)                                             
44: R34         Revenues - Contract Assets and Liabilities          HTML     43K 
                (Details)                                                        
45: R35         Collaboration Agreements And Business Development   HTML     38K 
                Activities - Collaboration Revenues under the                    
                Collaboration Agreement with Ipsen (Details)                     
46: R36         Collaboration Agreements And Business Development   HTML     31K 
                Activities - Ipsen Collaboration Narrative                       
                (Details)                                                        
47: R37         Collaboration Agreements And Business Development   HTML     38K 
                Activities - Collaboration Revenues under the                    
                Collaboration Agreement with Takeda (Details)                    
48: R38         Collaboration Agreements And Business Development   HTML     26K 
                Activities - Takeda Collaboration Narrative                      
                (Details)                                                        
49: R39         Collaboration Agreements And Business Development   HTML     30K 
                Activities - GSK Narrative (Details)                             
50: R40         Collaboration Agreements And Business Development   HTML     33K 
                Activities- Royalty Revenues under the                           
                Collaboration Agreement with Genentech (Details)                 
51: R41         Collaboration Agreements And Business Development   HTML     36K 
                Activities - Research Collaborations and                         
                In-Licensing Arrangements Narrative (Details)                    
52: R42         Cash and Investments - Reconciliation of Cash,      HTML     31K 
                Cash Equivalents, and Restricted Cash (Details)                  
53: R43         Cash and Investments - Narrative (Details)          HTML     41K 
54: R44         Cash and Investments - Investments by Security      HTML     71K 
                Type (Details)                                                   
55: R45         Cash and Investments - Fair Value and Gross         HTML     38K 
                Unrealized Losses of Investments                                 
                Available-for-Sale in an Unrealized Loss Position                
                (Details)                                                        
56: R46         Cash and Investments - Fair Value of Cash           HTML     31K 
                Equivalents and Investments by Contractual                       
                Maturity (Details)                                               
57: R47         Fair Value Measurements (Details)                   HTML     69K 
58: R48         Fair Value Measurements - Narratives (Details)      HTML     32K 
59: R49         Inventory (Details)                                 HTML     34K 
60: R50         Stock-Based Compensation - Schedule of Allocated    HTML     30K 
                Employee Stock-Based Compensation Expense                        
                (Details)                                                        
61: R51         Stock-Based Compensation - Schedule of Employee     HTML     34K 
                Service Share - Based Compensation Expense                       
                (Details)                                                        
62: R52         Stock-Based Compensation - Narrative (Details)      HTML     78K 
63: R53         Stock-Based Compensation - Estimate Grant-Date      HTML     32K 
                Fair Value (Details)                                             
64: R54         Provision For Income Taxes (Details)                HTML     24K 
65: R55         Net Income Per Share - Computation of Basic and     HTML     54K 
                Diluted Net Income Per Share (Details)                           
66: R56         Net Income Per Share - Potential Shares of Common   HTML     27K 
                Stock Not Included in the Computation of Diluted                 
                Net Income Per Share (Details)                                   
67: R57         Commitments and Contingencies (Details)             HTML     60K 
68: R58         Subsequent Events (Details)                         HTML     37K 
71: XML         IDEA XML File -- Filing Summary                      XML    132K 
69: XML         XBRL Instance -- exel-20220930_htm                   XML   1.90M 
70: EXCEL       IDEA Workbook of Financial Reports                  XLSX    125K 
 7: EX-101.CAL  XBRL Calculations -- exel-20220930_cal               XML    158K 
 8: EX-101.DEF  XBRL Definitions -- exel-20220930_def                XML    524K 
 9: EX-101.LAB  XBRL Labels -- exel-20220930_lab                     XML   1.32M 
10: EX-101.PRE  XBRL Presentations -- exel-20220930_pre              XML    792K 
 6: EX-101.SCH  XBRL Schema -- exel-20220930                         XSD    152K 
72: JSON        XBRL Instance as JSON Data -- MetaLinks              333±   508K 
73: ZIP         XBRL Zipped Folder -- 0000939767-22-000110-xbrl      Zip    495K 




        
Filing Submission 0000939767-22-000110 – SGML Text

Original SGML Text submitted by:  Exelixis, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 11:42:32.2pm ET